Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results CC transcript
|
Abraxis BioScience, Inc. (ABII)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/19/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
10/19/2010 |
4
| Michele B. Soon-Shiong 2009 Grantor Retained Annuity Trust 1 UAD 9/24/2009 (10% Owner) has filed a Form 4 on Abraxis BioScience, Inc. |
10/19/2010 |
4
| CHEN DAVID (Director) has filed a Form 4 on Abraxis BioScience, Inc.
Txns:
| Disposed/sold 10,000 options to buy
@ $38.08, valued at
$380.8k
Disposed/sold 1,909 options to buy
@ $29.44, valued at
$56.2k
Disposed/sold 1,909 options to buy
@ $34.65, valued at
$66.1k
Disposed/sold 1,272 options to buy
@ $82.94, valued at
$105.5k
Disposed/sold 1,272 options to buy
@ $95.26, valued at
$121.2k
Disposed/sold 2,970 options to buy
@ $94.84, valued at
$281.7k
Disposed/sold 4,243 options to buy
@ $47.3, valued at
$200.7k
Disposed/sold 10,000 options to buy
@ $55.44, valued at
$554.4k
|
|
10/19/2010 |
4
| NIMER STEPHEN (Director) has filed a Form 4 on Abraxis BioScience, Inc.
Txns:
| Disposed/sold 1,875 shares
@ $0 Disposed/sold 10,000 options to buy
@ $38.08, valued at
$380.8k
Disposed/sold 4,773 options to buy
@ $6.29, valued at
$30k
Disposed/sold 4,773 options to buy
@ $25.15, valued at
$120k
Disposed/sold 1,909 options to buy
@ $29.44, valued at
$56.2k
Disposed/sold 1,909 options to buy
@ $34.65, valued at
$66.1k
Disposed/sold 1,272 options to buy
@ $82.94, valued at
$105.5k
Disposed/sold 1,272 options to buy
@ $95.26, valued at
$121.2k
Disposed/sold 2,970 options to buy
@ $94.84, valued at
$281.7k
Disposed/sold 4,243 options to buy
@ $47.3, valued at
$200.7k
Disposed/sold 10,000 options to buy
@ $55.44, valued at
$554.4k
|
|
10/19/2010 |
4
| Patrick Soon-Shiong 2009 Grantor Annuity Trust 2 UAD 9/24/2009 (10% Owner) has filed a Form 4 on Abraxis BioScience, Inc. |
10/19/2010 |
4
| Patrick Soon-Shiong 2009 Grantor Retained Annuity Trust 1 UAD 9/24/2009 (10% Owner) has filed a Form 4 on Abraxis BioScience, Inc. |
10/19/2010 |
4
| SHAPIRO LEONARD (Director) has filed a Form 4 on Abraxis BioScience, Inc.
Txns:
| Disposed/sold 6,125 shares
@ $0 Disposed/sold 10,000 options to buy
@ $38.08, valued at
$380.8k
Disposed/sold 4,773 options to buy
@ $14.12, valued at
$67.4k
Disposed/sold 1,909 options to buy
@ $34.65, valued at
$66.1k
Disposed/sold 1,272 options to buy
@ $82.94, valued at
$105.5k
Disposed/sold 1,272 options to buy
@ $95.26, valued at
$121.2k
Disposed/sold 2,970 options to buy
@ $94.84, valued at
$281.7k
Disposed/sold 4,243 options to buy
@ $47.3, valued at
$200.7k
Disposed/sold 10,000 options to buy
@ $55.44, valued at
$554.4k
|
|
10/19/2010 |
4
| SITRICK MICHAEL S (Director) has filed a Form 4 on Abraxis BioScience, Inc.
Txns:
| Disposed/sold 10,000 options to buy
@ $38.08, valued at
$380.8k
|
|
10/19/2010 |
4
| SOON SHIONG PATRICK (Executive Chairman) has filed a Form 4 on Abraxis BioScience, Inc. |
10/19/2010 |
4
| Michele B. Soon-Shiong 2009 Grantor Retained Annuity Trust 2 UAD 9/24/2009 (10% Owner) has filed a Form 4 on Abraxis BioScience, Inc. |
10/19/2010 |
4
| Wendel Bruce (CEO) has filed a Form 4 on Abraxis BioScience, Inc. |
10/19/2010 |
4
| FOGELMAN MITCHELL K (CFO) has filed a Form 4 on Abraxis BioScience, Inc. |
10/18/2010 |
4
| CELGENE CORP /DE/ (10% Owner) has filed a Form 4 on Abraxis BioScience, Inc. |
03/17/2010 |
4
| FOGELMAN MITCHELL K (Acting CFO) has filed a Form 4 on Abraxis BioScience, Inc. |
03/17/2010 |
4
| SOON SHIONG PATRICK (Executive Chairman) has filed a Form 4 on Abraxis BioScience, Inc. |
03/17/2010 |
4
| Wendel Bruce (CEO) has filed a Form 4 on Abraxis BioScience, Inc. |
03/03/2010 |
4
| Wendel Bruce (CEO) has filed a Form 4 on Abraxis BioScience, Inc. |
03/03/2010 |
4
| SOON SHIONG PATRICK (Executive Chairman) has filed a Form 4 on Abraxis BioScience, Inc. |
02/26/2010 |
4
| SOON SHIONG PATRICK (Executive Chairman) has filed a Form 4 on Abraxis BioScience, Inc. |
02/11/2010 |
4
| SOON SHIONG PATRICK (Executive Chairman) has filed a Form 4 on Abraxis BioScience, Inc. |
01/26/2010 |
4
| SOON SHIONG PATRICK (Chairman and CEO) has filed a Form 4 on Abraxis BioScience, Inc. |
01/26/2010 |
4
| Wendel Bruce (Exec. VP Corporate Development) has filed a Form 4 on Abraxis BioScience, Inc. |
01/26/2010 |
4
| SOON SHIONG PATRICK (Chairman and CEO) has filed a Form 4 on Abraxis BioScience, Inc. |
12/14/2009 |
4
| NIMER STEPHEN (Director) has filed a Form 4 on Abraxis BioScience, Inc.
Txns:
| Granted 10,000 options to buy
@ $38.08, valued at
$380.8k
|
|
12/14/2009 |
4
| CALHOUN KIRK K (Director) has filed a Form 4 on Abraxis BioScience, Inc.
Txns:
| Granted 10,000 options to buy
@ $38.08, valued at
$380.8k
|
|
12/14/2009 |
4
| CHEN DAVID (Director) has filed a Form 4 on Abraxis BioScience, Inc.
Txns:
| Granted 10,000 options to buy
@ $38.08, valued at
$380.8k
|
|
12/14/2009 |
4
| SHAPIRO LEONARD (Director) has filed a Form 4 on Abraxis BioScience, Inc.
Txns:
| Granted 10,000 options to buy
@ $38.08, valued at
$380.8k
|
|
12/14/2009 |
4
| SITRICK MICHAEL S (Director) has filed a Form 4 on Abraxis BioScience, Inc.
Txns:
| Granted 10,000 options to buy
@ $38.08, valued at
$380.8k
|
|
11/12/2009 |
4
| Wendel Bruce (Exec. VP Corporate Development) has filed a Form 4 on Abraxis BioScience, Inc. |
07/15/2009 |
4
| Hedley Mary Lynne (Executive VP of Ops & CSO) has filed a Form 4 on Abraxis BioScience, Inc.
Txns:
| Granted 25,000 shares
@ $0 Granted 50,000 options to buy
@ $31.82, valued at
$1.6M
|
|
07/15/2009 |
4
| Rodgers Richard J (Senior Vice President and CFO) has filed a Form 4 on Abraxis BioScience, Inc.
Txns:
| Granted 15,000 shares
@ $0 Granted 20,000 options to buy
@ $31.82, valued at
$636.4k
|
|
05/01/2009 |
4
| MOULDER LEON O JR (President & CEO) has filed a Form 4 on Abraxis BioScience, Inc. |
03/03/2009 |
4
| SOON SHIONG PATRICK (Chairman and CEO) has filed a Form 4 on Abraxis BioScience, Inc. |
03/03/2009 |
4
| Geehr Ed (Executive VP Operations) has filed a Form 4 on Abraxis BioScience, Inc. |
|
|
|